SG11201703810QA - Dianhydrogalactitol together with radiation to treat non-small-cell carcinoma of the lung and glioblastoma multiforme - Google Patents
Dianhydrogalactitol together with radiation to treat non-small-cell carcinoma of the lung and glioblastoma multiformeInfo
- Publication number
- SG11201703810QA SG11201703810QA SG11201703810QA SG11201703810QA SG11201703810QA SG 11201703810Q A SG11201703810Q A SG 11201703810QA SG 11201703810Q A SG11201703810Q A SG 11201703810QA SG 11201703810Q A SG11201703810Q A SG 11201703810QA SG 11201703810Q A SG11201703810Q A SG 11201703810QA
- Authority
- SG
- Singapore
- Prior art keywords
- dianhydrogalactitol
- lung
- radiation
- small
- cell carcinoma
- Prior art date
Links
- AAFJXZWCNVJTMK-GUCUJZIJSA-N (1s,2r)-1-[(2s)-oxiran-2-yl]-2-[(2r)-oxiran-2-yl]ethane-1,2-diol Chemical compound C([C@@H]1[C@H](O)[C@H](O)[C@H]2OC2)O1 AAFJXZWCNVJTMK-GUCUJZIJSA-N 0.000 title 1
- 201000010915 Glioblastoma multiforme Diseases 0.000 title 1
- 229950000758 dianhydrogalactitol Drugs 0.000 title 1
- 208000005017 glioblastoma Diseases 0.000 title 1
- 208000002154 non-small cell lung carcinoma Diseases 0.000 title 1
- 230000005855 radiation Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/38—Albumins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Oncology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
- Radiation-Therapy Devices (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462077712P | 2014-11-10 | 2014-11-10 | |
| PCT/US2015/059814 WO2016077264A1 (en) | 2014-11-10 | 2015-11-10 | Dianhydrogalactitol together with radiation to treat non-small-cell carcinoma of the lung and glioblastoma multiforme |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201703810QA true SG11201703810QA (en) | 2017-06-29 |
Family
ID=55954912
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201703810QA SG11201703810QA (en) | 2014-11-10 | 2015-11-10 | Dianhydrogalactitol together with radiation to treat non-small-cell carcinoma of the lung and glioblastoma multiforme |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20190015379A1 (ko) |
| EP (1) | EP3217970A4 (ko) |
| JP (3) | JP2017536356A (ko) |
| KR (2) | KR20170081261A (ko) |
| CN (2) | CN107231794A (ko) |
| AU (1) | AU2015346598B2 (ko) |
| BR (1) | BR112017009845A2 (ko) |
| CA (1) | CA2967322A1 (ko) |
| CL (1) | CL2017001180A1 (ko) |
| IL (1) | IL252192B2 (ko) |
| MX (1) | MX2017006076A (ko) |
| SG (1) | SG11201703810QA (ko) |
| TW (1) | TW201632181A (ko) |
| WO (1) | WO2016077264A1 (ko) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11201703810QA (en) * | 2014-11-10 | 2017-06-29 | Del Mar Pharmaceuticals | Dianhydrogalactitol together with radiation to treat non-small-cell carcinoma of the lung and glioblastoma multiforme |
| WO2018204412A1 (en) * | 2017-05-01 | 2018-11-08 | Thomas Jefferson University | Systems-level analysis of tcga cancers reveals disease trna fragmentation patterns and associations with messenger rnas and repeat |
| EP3665202A1 (en) | 2017-08-09 | 2020-06-17 | Massachusetts Institute Of Technology | Albumin binding peptide conjugates and methods thereof |
| CN109512833B (zh) * | 2018-12-04 | 2020-10-30 | 天津医科大学总医院 | E2f6抑制剂的功能与用途 |
| WO2021207650A1 (en) * | 2020-04-09 | 2021-10-14 | L.E.A.F. Holdings Group Llc | Trans-crocetin compositions and treatment regimens |
| KR102560912B1 (ko) * | 2020-08-26 | 2023-07-28 | 한양대학교 에리카산학협력단 | 엑소좀을 유효성분으로 포함하는 폐암 치료, 예방 또는 전이 억제용 약학적 조성물 |
| CN113599524B (zh) * | 2021-09-02 | 2023-05-02 | 中国医学科学院肿瘤医院 | Hnrnpc和rbmx作为靶点在制备治疗小细胞肺癌的产品中的应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4801575A (en) * | 1986-07-30 | 1989-01-31 | The Regents Of The University Of California | Chimeric peptides for neuropeptide delivery through the blood-brain barrier |
| US4938949A (en) * | 1988-09-12 | 1990-07-03 | University Of New York | Treatment of damaged bone marrow and dosage units therefor |
| EP2915532B1 (en) * | 2008-06-17 | 2016-10-19 | Wyeth LLC | Antineoplastic combinations containing hki-272 and vinorelbine |
| JP2013537552A (ja) * | 2010-08-18 | 2013-10-03 | デル マー ファーマスーティカルズ | ジアンヒドロガラクチトール及びジアセチルジアンヒドロガラクチトール等の置換ヘキシトールを含む準最適に投与された化合物の治療的有効性を改良するための組成物及び方法 |
| WO2013110058A2 (en) * | 2012-01-20 | 2013-07-25 | Bacha Jeffrey | Use of substituted hexitols including dianhydrogalactitol and analogs to treat neoplastic disease and cancer stem cells including glioblastoma multforme and medulloblastoma |
| KR102359214B1 (ko) * | 2014-04-04 | 2022-02-07 | 델 마 파마슈티컬스 | 폐의 비소세포 암종 및 난소암을 치료하기 위한 디안하이드로갈락티톨 및 이의 유사체 또는 유도체 |
| SG11201703810QA (en) * | 2014-11-10 | 2017-06-29 | Del Mar Pharmaceuticals | Dianhydrogalactitol together with radiation to treat non-small-cell carcinoma of the lung and glioblastoma multiforme |
-
2015
- 2015-11-10 SG SG11201703810QA patent/SG11201703810QA/en unknown
- 2015-11-10 US US15/525,933 patent/US20190015379A1/en not_active Abandoned
- 2015-11-10 KR KR1020177015926A patent/KR20170081261A/ko not_active Application Discontinuation
- 2015-11-10 KR KR1020227046292A patent/KR20230008252A/ko not_active Application Discontinuation
- 2015-11-10 BR BR112017009845A patent/BR112017009845A2/pt not_active Application Discontinuation
- 2015-11-10 CN CN201580071196.6A patent/CN107231794A/zh active Pending
- 2015-11-10 EP EP15858948.1A patent/EP3217970A4/en active Pending
- 2015-11-10 CA CA2967322A patent/CA2967322A1/en active Pending
- 2015-11-10 AU AU2015346598A patent/AU2015346598B2/en active Active
- 2015-11-10 MX MX2017006076A patent/MX2017006076A/es unknown
- 2015-11-10 TW TW104136993A patent/TW201632181A/zh unknown
- 2015-11-10 IL IL252192A patent/IL252192B2/en unknown
- 2015-11-10 JP JP2017525080A patent/JP2017536356A/ja active Pending
- 2015-11-10 WO PCT/US2015/059814 patent/WO2016077264A1/en active Application Filing
- 2015-11-10 CN CN202211009952.0A patent/CN115414480A/zh active Pending
-
2017
- 2017-05-10 CL CL2017001180A patent/CL2017001180A1/es unknown
-
2020
- 2020-07-30 JP JP2020129093A patent/JP2020183445A/ja active Pending
-
2022
- 2022-09-08 JP JP2022142672A patent/JP2022174200A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2015346598A1 (en) | 2017-06-08 |
| JP2017536356A (ja) | 2017-12-07 |
| CL2017001180A1 (es) | 2017-12-29 |
| CN115414480A (zh) | 2022-12-02 |
| EP3217970A1 (en) | 2017-09-20 |
| IL252192B1 (en) | 2023-11-01 |
| MX2017006076A (es) | 2017-12-11 |
| US20190015379A1 (en) | 2019-01-17 |
| TW201632181A (zh) | 2016-09-16 |
| JP2022174200A (ja) | 2022-11-22 |
| CA2967322A1 (en) | 2016-05-19 |
| JP2020183445A (ja) | 2020-11-12 |
| EP3217970A4 (en) | 2018-07-18 |
| IL252192B2 (en) | 2024-03-01 |
| WO2016077264A1 (en) | 2016-05-19 |
| KR20170081261A (ko) | 2017-07-11 |
| IL252192A0 (en) | 2017-07-31 |
| BR112017009845A2 (pt) | 2018-01-16 |
| KR20230008252A (ko) | 2023-01-13 |
| CN107231794A (zh) | 2017-10-03 |
| AU2015346598B2 (en) | 2020-09-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL272820B (en) | The history of sulfamoylpyrrolamide and their use as drugs to treat jaundice b | |
| IL248189B (en) | Use of dianhydrogalacticol type substances to treat lung cancer and ovarian cancer | |
| ZA201607415B (en) | Antibody-drug-conjugate and its use for the treatment of cancer | |
| HK1216991A1 (zh) | 癌疫苗及使用其的治療方法 | |
| ZA201602380B (en) | Cancer treatment with combination of plinabulin and taxane | |
| IL252192A0 (en) | Dihydrogalactitol together with radiation for the treatment of non-small cell lung cancer and glioblastoma multiforme | |
| GB201404470D0 (en) | Therapeutic methods and materials | |
| HRP20190888T8 (hr) | Konjugat antitijela za igf-1r i lijeka i njegova upotreba u liječenju karcinoma | |
| IL276733A (en) | Use of Aribolin in cancer treatment | |
| GB2516335B (en) | The use of phytocannabinoids in the treatment of ovarian carcinoma | |
| IL251903B (en) | Epilimod for use in the treatment of colon cancer | |
| PL3258931T3 (pl) | Zastosowanie kabazitakselu w leczeniu nowotworu złośliwego prostaty | |
| GB201416605D0 (en) | Combination therapy to reduce the risk of and to treat cancer | |
| GB201403086D0 (en) | Selection of virus and agent useful in the treatment of cancer | |
| SG10201802995SA (en) | Cancer treatment with combination of plinabulin and taxane |